Stan Gee Louie, PharmD

Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy

Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.

Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.

Jing Liang, MD, PhD

Professor · USC School of Pharmacy

Expert in drug development. Established targeting gephyrin-GABAAR pathway, a NOVEL THEORY, to intervene Alzheimer disease

Mitochondrial Anxiety Disorders GABA A Receptor Drug Development Neuroscience

Jan D. Hirsch

Founding Dean, School of Pharmacy and Pharmaceutical Sciences · UC Irvine

Jan Hirsch's research interests are focused in the areas of pharmacoeconomics and outcomes research.

Drug Development Gout Impact Scale Pharmacoeconomics Pharmaeutical Services Clinical Pharmacy

Thomas D. Roper, Ph.D.

Director, Pharmaceutical Engineering and Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Dr. Roper specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.

Metabolic Engineering and Biocatalysis 3D Printing of Dose Forms Long Acting Therapy Development Nanomaterials and Particle Sciences Continuous Chemical Reaction Engineering

Nancy Pire-Smerkanich, DRSc, MS

Assistant Professor of Regulatory and Quality Sciences · USC School of Pharmacy

Nancy Pire-Smerkanich brings over 30 years of industry experience in drug development to academia

Regulatory Filing Strategy Clinical Regulatory Guidance Drug Development

Adam Buckley

Vice President, Operations · VBI Vaccines

Adam Buckley is an expert in the biotechnology industry, specializing in the areas vaccines, technology transfer and drug development.

Lifesciences Drug Development Vaccines Biotechnology Technology Transfer

Prof. Elias Mossialos

Professor of Health Policy · Department of Social Policy, London School of Economics

Professor Mossialos's research interests are health systems and policy, with a specific focus on the impact of EU law on health care systems

Long Term Care European Health Policy Comparative Health Policy Funding Health Care Health Services Research

Julio A. Camarero, PhD

John A. Biles Professor in Pharmaceutical Sciences · USC School of Pharmacy

An expert in biological therapeutics, microbial pathogenicity, and protein and peptide therapeutics.

Inteins Bio-organic Chemistry Biological Therapeutics Microbial Pathogenicity Protein and peptide therapeutics

B. Frank Gupton, Ph.D.

Floyd D. Gottwald Junior Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis

Cross-Coupling Catalysis Flow Chemistry / Continual Chemical Processing Organic Synthesis in Pharmaceutical Applications

Ian S. Haworth, PhD

Associate Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

Ian Haworth's research focuses on bioinformatics, computer-aided drug design and therapeutic drug development.

Computational Chemistry and Immunology Computer-aided Drug Design Protein Structure DNA and RNA structure Computer-aided Molecular Design

Jan Hirsch

Professor of Clinical Pharmacy & Chair, Division of Clinical Pharmacy · UC San Diego

Jan Hirsch's research interests are focused in the areas of pharmacoeconomics and outcomes research.

Clinical Pharmacy Rheumatology Disease-specific Instruments Pharmaeutical Services Gout Impact Scale

Vassilios Papadopoulos, DPharm, PhD, DSc (Hon)

Dean, USC School of Pharmacy, John Stauffer Dean's Chair in Pharmaceutical Sciences & Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

An expert in pathophysiology and treatment of diseases related to altered steroid hormone synthesis.

Steroid hormone biosynthesis Hypogonadism Cancer Endocrine Pathologies Male Reproductive Disorders

Melina Kibbe

Colin G. Thomas, Jr., MD Distinguished Professor · UNC-Chapel Hill

Dr. Kibbe’s expertise is in open and endovascular surgery and in novel therapies to treat cardiovascular disease

Mentorship and Career Development Gender Inclusion Sex Bias Biomedical Engineering Nanotechnology

Gerry Brunk

Managing Director · Lumira Capital

Gerry Brunk expertise lies in investment, consulting and entrepreneurial work in the health care and life science sectors.

Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization

Klaus Romero, MD, MS, FCP

Adjunct Professor of Clinical Pharmacy · USC School of Pharmacy

Klaus Romero is a clinical pharmacologist and epidemiologist who has developed models to predict the efficacy and safety of medications.

Quantitative Medicine Pharmacoepidemiology Pharmacometrics

Ramani Varanasi

President and CEO · X-Biotix Therapeutics

Ramani Varanasi is a biopharmaceutical expert with experience structuring, negotiating and executing successful strategic alliances.

Clinical Trials Molecular Biology Oncology Pharmaceutical Industry Biotechnology

Edie Dullaghan

Head, Target Validation · Centre for Drug Research and Development

Striving for excellence through mentoring people and by fostering creative/critical thinking,

Drug Development Infectious Disease Biology Molecular Genetics of Gene Expression Immunohistochemistry Antibiotic development

Riccardo Panicucci

Senior VP CMC · QED Therapeutics and Origin Biosciences

Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.

Technology Transfer Biotechnology Clinical Development Drug Discovery Drug Development

Paul Jansen

Board Member and Senior Advisor · Haselmeier Group

Paul Jansen is an experienced pharmaceutical industry professional with expertise in drug and biologics device development.

Biotechnology Pharmaceutical Industry Drug Development Biologics Device Development Product Launch

Karla MacDonald

Vice President, Communication and Patient Advocacy · Ipsen

Karla MacDonald is an expert in strategy, leading communications and building talent for companies ranging from biotechs to large pharma.

Corporate Communications Pharmaceutical Industry Strategic Communications Patient Advocacy Drug Development

Please enter the email address you signed up with. We will send you an email that you can use to reset your password.

Please check your inbox

We will send you an email to reset your password.